Nelson, C. H., Etchevers, K., Yi, S., Breckenridge, D., Hepner, M., Patel, U., . . . Mathias, A. (2020). Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects. Clinical pharmacokinetics, 59(9), 1109-1117. https://doi.org/10.1007/s40262-020-00878-y
Citace podle Chicago (17th ed.)Nelson, Cara H., Kim Etchevers, Saili Yi, David Breckenridge, Mischa Hepner, Uptal Patel, John Ling, a Anita Mathias. "Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects." Clinical Pharmacokinetics 59, no. 9 (2020): 1109-1117. https://doi.org/10.1007/s40262-020-00878-y.
Citace podle MLA (9th ed.)Nelson, Cara H., et al. "Pharmacokinetics, Safety, and Tolerability of Selonsertib, an Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitor, Following First-in-Human Single and Multiple Ascending Doses in Healthy Subjects." Clinical Pharmacokinetics, vol. 59, no. 9, 2020, pp. 1109-1117, https://doi.org/10.1007/s40262-020-00878-y.